233 related articles for article (PubMed ID: 19543844)
41. Psychiatric morbidity and social functioning among adults with borderline intelligence living in private households.
Hassiotis A; Strydom A; Hall I; Ali A; Lawrence-Smith G; Meltzer H; Head J; Bebbington P
J Intellect Disabil Res; 2008 Feb; 52(Pt 2):95-106. PubMed ID: 18197948
[TBL] [Abstract][Full Text] [Related]
42. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.
Kessler RC; McGonagle KA; Zhao S; Nelson CB; Hughes M; Eshleman S; Wittchen HU; Kendler KS
Arch Gen Psychiatry; 1994 Jan; 51(1):8-19. PubMed ID: 8279933
[TBL] [Abstract][Full Text] [Related]
43. Panic attack as a risk factor for severe psychopathology.
Goodwin RD; Lieb R; Hoefler M; Pfister H; Bittner A; Beesdo K; Wittchen HU
Am J Psychiatry; 2004 Dec; 161(12):2207-14. PubMed ID: 15569891
[TBL] [Abstract][Full Text] [Related]
44. [Substance use, affective problems and personality traits: test of two association models].
Chakroun N; Doron J; Swendsen J
Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
[TBL] [Abstract][Full Text] [Related]
45. DSM-III-R personality disorders in a mood and anxiety disorders clinic: prevalence, comorbidity, and clinical correlates.
Flick SN; Roy-Byrne PP; Cowley DS; Shores MM; Dunner DL
J Affect Disord; 1993 Feb; 27(2):71-9. PubMed ID: 8440809
[TBL] [Abstract][Full Text] [Related]
46. DSM-IV axis II comorbidity with borderline personality disorder in monolingual Hispanic psychiatric outpatients.
Grilo CM; Miguel Anez L; McGlashan TH
J Nerv Ment Dis; 2002 May; 190(5):324-30. PubMed ID: 12011613
[TBL] [Abstract][Full Text] [Related]
47. Mental capacity, diagnosis and insight in psychiatric in-patients: a cross-sectional study.
Owen GS; David AS; Richardson G; Szmukler G; Hayward P; Hotopf M
Psychol Med; 2009 Aug; 39(8):1389-98. PubMed ID: 18940026
[TBL] [Abstract][Full Text] [Related]
48. Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population.
Gaynes BN; Pence BW; Eron JJ; Miller WC
Psychosom Med; 2008 May; 70(4):505-11. PubMed ID: 18378865
[TBL] [Abstract][Full Text] [Related]
49. Attitudes of staff towards patients with personality disorder in community mental health teams.
Newton-Howes G; Weaver T; Tyrer P
Aust N Z J Psychiatry; 2008 Jul; 42(7):572-7. PubMed ID: 18612860
[TBL] [Abstract][Full Text] [Related]
50. Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity.
Vélez-Pastrana MC; González RA; Ramos-Fernández A; Ramírez Padilla RR; Levin FR; Albizu García C
Eur Addict Res; 2020; 26(4-5):179-190. PubMed ID: 32615575
[TBL] [Abstract][Full Text] [Related]
51. The performance of the Health of the Nation Outcome Scales as measures of clinical severity.
Müller M; Vandeleur C; Weniger G; Prinz S; Vetter S; Egger ST
Psychiatry Res; 2016 May; 239():20-7. PubMed ID: 27137958
[TBL] [Abstract][Full Text] [Related]
52. Mental comorbidity of chronic insomnia in general practice attenders using DSM-III-R.
Schramm E; Hohagen F; Käppler C; Grasshoff U; Berger M
Acta Psychiatr Scand; 1995 Jan; 91(1):10-7. PubMed ID: 7754780
[TBL] [Abstract][Full Text] [Related]
53. Axis I psychiatric symptoms associated with HIV infection and personality disorder.
Johnson JG; Williams JB; Rabkin JG; Goetz RR; Remien RH
Am J Psychiatry; 1995 Apr; 152(4):551-4. PubMed ID: 7694903
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
[TBL] [Abstract][Full Text] [Related]
55. DSM-IV personality disorders in the National Comorbidity Survey Replication.
Lenzenweger MF; Lane MC; Loranger AW; Kessler RC
Biol Psychiatry; 2007 Sep; 62(6):553-64. PubMed ID: 17217923
[TBL] [Abstract][Full Text] [Related]
56. Extent of comorbidity between mental state and personality disorders.
Tyrer P; Gunderson J; Lyons M; Tohen M
J Pers Disord; 1997; 11(3):242-59. PubMed ID: 9348488
[TBL] [Abstract][Full Text] [Related]
57. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Conway KP; Compton W; Stinson FS; Grant BF
J Clin Psychiatry; 2006 Feb; 67(2):247-57. PubMed ID: 16566620
[TBL] [Abstract][Full Text] [Related]
58. Co-occurring mental illness, substance use disorders, and antisocial personality disorder among clients of forensic mental health services.
Ogloff JR; Talevski D; Lemphers A; Wood M; Simmons M
Psychiatr Rehabil J; 2015 Mar; 38(1):16-23. PubMed ID: 25799303
[TBL] [Abstract][Full Text] [Related]
59. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders.
Skodol AE; Oldham JM; Gallaher PE
Am J Psychiatry; 1999 May; 156(5):733-8. PubMed ID: 10327906
[TBL] [Abstract][Full Text] [Related]
60. Mental illness in adults with fetal alcohol syndrome or fetal alcohol effects.
Famy C; Streissguth AP; Unis AS
Am J Psychiatry; 1998 Apr; 155(4):552-4. PubMed ID: 9546004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
